[REGN] YoY Quarter Result on 31-Dec-2014 [#Q4]

Stock
[REGN] Regeneron Pharmaceuticals, Inc.
Announcement Date
12-Feb-2015
Financial Year
2014
Quarter
31-Dec-2014 [#Q4]
Profit Trend
QoQ- 38.20%
YoY- 13.81%
Quarter Report
REGN's Result
REGN's Financial Summary
View:
Show?
Quarter Result
31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 CAGR
Revenue 1,582,447 1,226,827 1,098,077 802,329 610,412 414,602 122,977 53.02%
PBT 554,767 341,527 227,289 221,287 198,153 134,559 -54,058 -
Tax 381,248 88,412 72,295 111,111 101,347 -335,848 -615 -
NP 173,519 253,115 154,994 110,176 96,806 470,407 -53,443 -
Tax Rate -68.72% -25.89% -31.81% -50.21% -51.15% 249.59% - -
Total Cost 1,408,928 973,712 943,083 692,153 513,606 -55,805 176,420 41.33%
Ratio Analysis
31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 CAGR
NP Margin 10.97 20.63 14.12 13.73 15.86 113.46 -43.46 -
Per Share
31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 CAGR
EPS 1.62 2.41 1.49 0.89 0.98 4.92 -0.58 -
EPS Diluted 1.49 2.19 1.34 0.79 0.73 4.26 -0.57 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.